Michael Mendelsohn, MD

Michael Mendelsohn, M.D. has served as a member of our Board of Directors since April 2017. He is a physician-scientist, research leader, and industry executive with broad experience in healthcare.

Previously, Michael served as the senior vice president and head of cardiovascular research at Merck Research Laboratories, with overall responsibility for the scientific direction of cardiovascular research from drug discovery through late development. He formerly served as a venture partner at SV Life Sciences and became executive chairman of Cardurion Pharmaceuticals.

Michael is a professor of medicine and cardiology at Tufts Medical Center and Tufts University School of Medicine, where he also served as the first chief scientific officer and was founder and executive director of the Molecular Cardiology Research Institute. Prior to that, he served on the cardiovascular faculty of Brigham and Women’s Hospital and Harvard Medical School.

Michael completed an internal medicine internship and residency followed by a fellowship in cardiovascular medicine at Brigham and Women’s Hospital and Harvard Medical School. He received his B.A. in chemistry and English from Amherst College, in Massachusetts, and his M.D. from Harvard Medical School.